Get the Stockscreener App
338.48
0.22%
0.75
After Hours:
338.48
Bio Rad Laboratories Inc stock is traded at $338.48, with a volume of 122.61K.
It is up +0.22% in the last 24 hours and up +5.70% over the past month.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
See More
Previous Close:
$337.73
Open:
$341.75
24h Volume:
122.61K
Relative Volume:
0.46
Market Cap:
$9.57B
Revenue:
$2.58B
Net Income/Loss:
$-778.69M
P/E Ratio:
-57.86
EPS:
-5.85
Net Cash Flow:
$223.75M
1W Performance:
+4.57%
1M Performance:
+5.70%
6M Performance:
+17.85%
1Y Performance:
+10.20%
1-Day Range:
$336.77
$345.49
1-Week Range:
$320.32
$345.49
52-Week Range:
$262.12
$387.99
Bio Rad Laboratories Inc Stock (BIO) Company Profile
Name
Bio Rad Laboratories Inc
Sector
Industry
Phone
(510) 724-7000
Address
1000 ALFRED NOBEL DRIVE, HERCULES
Compare BIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
338.48 | 9.57B | 2.58B | -778.69M | 223.75M | -5.85 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-01-24 | Upgrade | Citigroup | Neutral → Buy |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Apr-03-24 | Downgrade | Citigroup | Buy → Neutral |
| Dec-07-23 | Initiated | UBS | Buy |
| Jun-16-23 | Initiated | Wells Fargo | Overweight |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jan-28-22 | Reiterated | Citigroup | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Oct-17-18 | Initiated | Goldman | Buy |
| Sep-20-18 | Initiated | Morgan Stanley | Equal-Weight |
| Feb-16-18 | Downgrade | CL King | Buy → Neutral |
| Jul-13-17 | Initiated | Wells Fargo | Outperform |
| Jun-28-17 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-18-17 | Initiated | Deutsche Bank | Hold |
| Oct-13-16 | Initiated | CL King | Buy |
| May-06-15 | Reiterated | Jefferies | Buy |
| Dec-18-09 | Initiated | Maxim Group | Buy |
| Nov-06-09 | Initiated | Jefferies & Co | Buy |
| Jul-17-09 | Initiated | Soleil | Buy |
| Sep-26-07 | Initiated | Banc of America Sec | Buy |
| Feb-23-07 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Bio Rad Laboratories Inc Stock (BIO) Latest News
Electrophoresis Reagents Market Size, Trends Analysis 2031 - openPR
Next Generation Sequencing (NGS) Market Expected to Reach USD - openPR
Personalized Medicines Market to Surpass Valuation of USD 1352.81 Billion by 2031 | SkyQuest Technology - GlobeNewswire Inc.
Bio-Rad Laboratories (FRA:BUWA) 3-Year Revenue Growth Rate : 2.70% (As of Sep. 2024) - GuruFocus.com
Food Safety Testing Market to Grow by USD 10.51 Billion (2024-2028), Government Agency Involvement Boosts Growth, Report on AI Redefining Market LandscapeTechnavio - The Malaysian Reserve
Bio-Rad Laboratories (STU:BUWA) Peter Lynch Fair Value : N/A (As of Nov. 26, 2024) - GuruFocus.com
DRW Securities LLC Makes New Investment in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Massachusetts Financial Services Co. MA Has $18.12 Million Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Custom Antibody Service Market Generated Opportunities, - openPR
BIO (Bio-Rad Laboratories) 3-Year Book Growth Rate : -2.50% (As of Sep. 2024) - GuruFocus.com
Why Bio-Rad Laboratories Is Overvalued: A Fundamental And DCF Analysis (NYSE:BIO) - Seeking Alpha
Is Bio-Rad Laboratories, Inc. (NYSE:BIO) Potentially Undervalued? - Simply Wall St
In Vitro Diagnostics (IVD) Quality Control Global Market Report - openPR
What is Zacks Research's Forecast for BIO FY2024 Earnings? - MarketBeat
Sexually Transmitted Disease (STD) Testing Market Size, Growth - openPR
Bio-Rad Laboratories, Inc. (BIO): A Bull Case Theory - MSN
Westfield Capital Management Co. LP Raises Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Mutual of America Capital Management LLC Buys 7,777 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
CIBC Asset Management Inc Sells 2,037 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Zacks Research Analysts Lower Earnings Estimates for BIO - MarketBeat
Horseradish Peroxidase Market Company Profiles, Segments, - openPR
Metagenomics Market Is Booming Worldwide 2024-2031 | Bio-Rad - openPR
Cancer Monoclonal Antibodies Market Overall Study Report - openPR
Legionella Testing Market Report 2022Non-Invasive - openPR
Bio-Rad’s Management to Host Investor Meetings at Citi's 2024 Global Healthcare Conference - BioSpace
Thompson Siegel & Walmsley LLC Sells 83,227 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
One Step RT-qPCR Kits Market Key Players AnalysisTakara Bio - openPR
Natixis Advisors LLC Increases Stock Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Leukemia Screening Market Future Business Opportunities - openPR
Custom Antibody Services Market Report: Detailed Insights - openPR
Cell Signaling Market: Opportunities, Challenges, and Growth - openPR
Electrophoresis Reagents Market: Company Profiles, Segment - openPR
Hematology Testing Products Market Statistical Forecast - openPR
Biological Multiplex Assays Market to Witness Significant - openPR
IVD quality control Market Share, Trends, Top Players, Segments - openPR
Biochips Market Opportunities and Trends With Leading Key - openPR
DNA Extraction Kits Market Is Booming Worldwide 2024-2031 | - openPR
Cell Viability Assays Market Opportunities and Trends - openPR
DNA Sequencing Market Enhanced Profitability, And Supply - openPR
Protein Engineering Market Projected to Reach USD 7.39 Billion by 2032 with a CAGR of 14.72% - GlobeNewswire Inc.
Mawer Investment Management Ltd. Boosts Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Protein Chip Market Growth, Industry Development and Forecast - openPR
Genomic Biomarker Market 2024 Opportunity, Challenge, - openPR
Laboratory Mixer Market Strong Industry Growth, Business - openPR
Research Antibodies Market Report Outlines Revenue Share, SWOT - openPR
Genomic Biomarker Market Dynamics and Forecast Comprehensive - openPR
Bio-Rad Laboratories, Inc. (NYSE:BIO) Stake Lowered by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Sumitomo Mitsui Trust Group Inc. Trims Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
StarBright Yellow 561: A reliable alternative to PE-tandem dyes - News-Medical.Net
Clinical Diagnostics Market to Reach $ 110.0 Billion by 2031 | - openPR
Multiplexed Diagnostics Market Share, Trends, Top Players, - openPR
Bio Rad Laboratories Inc Stock (BIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):